YPR059C Antibody (Product Code: CSB-PA314370XA01SVG) is a polyclonal antibody generated against the YPR059C protein, a hypothetical ORF in S. cerevisiae. This antibody is primarily utilized in molecular biology to study yeast gene expression, protein localization, and functional genomics. It is produced via recombinant methods, ensuring high specificity and reproducibility .
Target Protein: YPR059C (UniProt ID: P0C5E1)
Host Species: Rabbit
Isotype: IgG
Immunogen: Synthetic peptide derived from the YPR059C protein sequence .
Like all IgG antibodies, YPR059C Antibody comprises:
Fab region: Binds specifically to YPR059C epitopes.
Fc region: Mediates immune effector functions (e.g., complement activation) .
Post-translational glycosylation in the Fc region influences stability and binding to Fc receptors .
YPR059C Antibody is widely used in:
Western Blot (WB): Detects YPR059C expression in yeast lysates .
Immunoprecipitation (IP): Isolates YPR059C-protein complexes for interactome studies .
| Application | Dilution | Sample Type |
|---|---|---|
| Western Blot | 1:200–1:1000 | S. cerevisiae lysate |
| Immunoprecipitation | 0.5–4.0 µg per 1–3 mg lysate | Yeast protein extract |
YPR059C Antibody shares production workflows with recombinant antibodies described in therapeutic research, such as codon optimization and protein A purification .
Genomic Annotation: Facilitates functional studies of poorly characterized yeast genes .
Tool Development: Serves as a control in antibody validation pipelines, akin to Rabbit IgG controls .
Therapeutic Analogues: Methods used to produce YPR059C Antibody mirror those for clinical antibodies (e.g., anti-PF4 antibodies in VITT studies) .
CRISPR/Cas9 Validation: Confirm YPR059C knockout phenotypes using antibody-based detection .
Structural Studies: Resolve YPR059C’s 3D structure via cryo-EM, leveraging antibody-antigen complexes .
Cross-Species Analysis: Test cross-reactivity with orthologs in pathogenic fungi .
Spiegelberg, H. L. (1989). Fc receptors. Immunology Today.
GENEWIZ. (2025). Recombinant Antibody Production.
Cusabio. (2025). YPR059C Antibody Specifications.
AbDb. (2018). Antibody Structure Database.
Thiele et al. (2021). Deglycosylated Anti-PF4 Antibodies.
Wikipedia. (2001). Antibody Structure and Function.
Proteintech. (2025). Rabbit IgG Control Antibody.
Abanades et al. (2023). PLAbDab Antibody Database.
What is YPR059C and what experimental applications require antibodies against it?
YPR059C is a yeast gene that contains an upstream open reading frame (uORF) that acts as a weak repressor . It has been identified in studies related to oxidative stress tolerance pathways . When developing experimental approaches to study this gene, researchers should consider:
ChIP analysis: YPR059C has been studied using chromatin immunoprecipitation with specific antibodies to analyze its genomic associations
Expression studies: Antibodies enable quantification of protein levels under different conditions
Localization analysis: Determine subcellular distribution using immunofluorescence
Interaction studies: Identify binding partners through co-immunoprecipitation
Functional analysis: Investigate its role in stress response mechanisms, particularly oxidative stress
What experimental techniques are most effective with YPR059C antibodies?
Several techniques yield robust results with YPR059C antibodies:
For ChIP applications, follow established protocols for Saccharomyces cerevisiae that typically involve formaldehyde crosslinking, cell lysis, chromatin sonication, immunoprecipitation, and analysis by qPCR or sequencing .
How should researchers validate YPR059C antibodies before experimental use?
A systematic validation approach involves:
Step 1: Genetic validation
Test antibody in wild-type vs. YPR059C deletion strains
Expected outcome: Signal present in wild-type, absent in deletion strain
Step 2: Epitope verification
Test with tagged YPR059C (e.g., FLAG-YPR059C)
Compare signal pattern between anti-YPR059C and anti-tag antibodies
Expected outcome: Co-localization confirms epitope specificity
Step 3: Application-specific validation
For Western blot: Confirm single band of expected molecular weight
For immunoprecipitation: Mass spectrometry verification of pulled-down protein
For ChIP: Enrichment at expected genomic regions
Step 4: Cross-reactivity assessment
Test against closely related yeast proteins
Peptide competition assays to confirm specificity
How should I design a ChIP experiment to study YPR059C binding to genomic regions?
Based on established chromatin immunoprecipitation protocols for yeast , implement the following workflow:
Experimental setup:
Culture preparation: Grow yeast to mid-log phase (5×10^6 cells/ml) in appropriate media
Crosslinking: Add formaldehyde to 1% final concentration and incubate for 15-20 minutes
Quenching: Add glycine to 125mM final concentration
Cell harvesting: Centrifuge and wash cell pellets
Cell lysis: Use glass beads or enzymatic methods optimized for yeast
Chromatin fragmentation: Sonicate to achieve 200-500bp fragments
Immunoprecipitation: Incubate fragmented chromatin with YPR059C antibody
Washing: Remove non-specific interactions with increasingly stringent buffers
Elution and reversal of crosslinks: Typically 65°C overnight treatment
DNA purification: Column-based methods for optimal recovery
Analysis: qPCR targeting regions of interest or genome-wide sequencing
Critical optimization parameters:
Antibody amount: Titrate from 1-10μg per IP reaction to determine optimal concentration
Washing stringency: Balance between reducing background and maintaining specific interactions
Sonication conditions: Optimize time and power settings for your specific sonicator model
What are the essential controls when investigating YPR059C under different cellular stresses?
When studying YPR059C's role in stress response pathways, particularly oxidative stress , incorporate these controls:
Genetic controls:
YPR059C deletion strain: Confirms antibody specificity and provides negative control
YPR059C overexpression strain: Demonstrates signal correlation with protein abundance
Tagged YPR059C strain: Allows correlation between target antibody and tag-specific antibody
Treatment controls:
Dose response: Multiple concentrations of stressor (e.g., H₂O₂ for oxidative stress)
Time course: Capture dynamic changes in YPR059C response
Recovery phase: Monitor return to baseline after stress removal
Technical controls:
Loading controls: Antibodies against constitutively expressed proteins
Secondary antibody-only: Detects non-specific binding of detection system
Isotype control: Primary antibody of same isotype but irrelevant specificity
Data analysis controls:
Biological replicates: Minimum of three independent experiments
Technical replicates: Multiple measurements within each biological replicate
Normalization methods: Account for variations in cell number and protein content
How can I optimize yeast transformation protocols when creating strains for YPR059C antibody studies?
When generating yeast strains for YPR059C antibody validation or functional studies, optimize the transformation protocol as follows :
Pre-transformation preparation:
Culture cells to mid-log phase (OD₆₀₀ = 0.6-0.8)
Prepare competent cells using lithium acetate method
Use high-quality plasmid DNA or PCR products with sufficient homology arms
Transformation procedure:
Centrifuge competent cells at 5000×g for 2 minutes
Add transformation mix (360μL) containing DNA, carrier DNA, PEG, and lithium acetate
Heat shock at 42°C for 40 minutes (this extended time is optimal for yeast)
Recover cells in YPD medium for 1.5 hours at 30°C
Optimization strategies:
Adjust DNA amount: Test 100ng-1μg range
Modify heat shock duration: 30-45 minutes depending on strain sensitivity
Vary PEG concentration: 35-45% for optimal balance of efficiency and cell viability
Verification methods for YPR059C modification:
PCR verification of genomic modifications
Western blot with YPR059C antibodies to confirm altered expression
Functional assays to assess phenotypic changes
How should I interpret contradictory results from different YPR059C antibodies in ChIP experiments?
When faced with discrepancies between antibodies targeting YPR059C, implement this systematic troubleshooting approach:
Step 1: Antibody characterization comparison
Epitope location: Different antibodies may target distinct regions of YPR059C
Clonality: Monoclonal antibodies target single epitopes while polyclonals recognize multiple sites
Production methods: Different immunization strategies can affect specificity
Step 2: Experimental validation
Peptide competition assay: Pre-incubate antibodies with immunizing peptide
YPR059C deletion strain: Test both antibodies against knockout control
Tagged YPR059C: Compare antibody signals with anti-tag antibody signal
Step 3: Technical consideration matrix
| Factor | Potential Impact | Resolution Approach |
|---|---|---|
| Fixation method | May affect epitope accessibility | Test multiple fixation protocols |
| Chromatin fragmentation | Influences epitope exposure | Optimize sonication conditions |
| Buffer composition | Affects antibody binding affinity | Test different IP buffers |
| Washing stringency | Changes signal-to-noise ratio | Perform titration of wash buffer stringency |
| Crossreactivity | Non-specific binding to related proteins | Perform immunoprecipitation followed by mass spectrometry |
Step 4: Biological context analysis
Consider post-translational modifications that might affect epitope recognition
Evaluate protein complex formation that could mask certain epitopes
Assess potential alternative splice variants or protein isoforms
What statistical approaches should be applied when analyzing ChIP-seq data for YPR059C binding sites?
A robust statistical framework for ChIP-seq data analysis includes:
Quality control and preprocessing:
Read quality assessment: Filter low-quality sequences (PHRED score <20)
Adapter trimming: Remove sequencing adapters
Alignment to reference genome: Use S. cerevisiae genome (recommend Bowtie2 or BWA)
PCR duplicate removal: Eliminate amplification artifacts
Fragment size distribution analysis: Verify successful chromatin fragmentation
Peak calling and identification:
Peak detection: Use MACS2 with p-value threshold of 10^-5
Signal normalization: Apply methods like RPKM or TMM
Background correction: Use input DNA or IgG control samples
False discovery rate control: Apply Benjamini-Hochberg correction
Differential binding analysis:
For condition comparisons: Use DiffBind or MAnorm packages
Normalize for sequencing depth differences
Apply fold-change thresholds (typically >2-fold) and statistical significance cutoffs (p<0.05)
Functional analysis:
Genomic feature association: Determine binding patterns relative to genes
Motif analysis: Identify DNA sequence preferences
Integration with gene expression: Correlate binding with transcriptional changes
Pathway enrichment: Connect targets to biological processes
How can I distinguish between signal artifacts and genuine YPR059C binding in immunolocalization studies?
To discriminate between true signals and artifacts in YPR059C localization studies:
Experimental approaches:
Specificity controls
Pre-immune serum comparison: Should show minimal background
YPR059C deletion strain: Should show no specific signal
Antibody pre-absorption: Pre-incubate with purified antigen to block specific binding
Sample preparation controls
Compare different fixation methods: Formaldehyde, methanol, etc.
Test various permeabilization protocols: Optimize for YPR059C accessibility
Implement antigen retrieval techniques if necessary
Imaging controls
Z-stack acquisition: Distinguish true signal from focal plane artifacts
Spectral controls: Verify fluorophore emission spectra to eliminate bleed-through
Multiple exposure settings: Determine detection threshold optimization
Quantitative validation:
Signal quantification across multiple cells (n>30)
Statistical comparison between experimental and control samples
Correlation with orthogonal methods (e.g., fractionation studies, tagged proteins)
Co-localization analysis with known cellular markers
How can YPR059C antibodies be used to investigate its role in oxidative stress response pathways?
YPR059C has been implicated in oxidative stress tolerance , and antibodies enable several advanced investigation approaches:
Dynamic expression profiling:
Subject yeast to oxidative stressors (H₂O₂, menadione, paraquat)
Collect time-course samples (5, 15, 30, 60, 120 min post-exposure)
Perform Western blot analysis with YPR059C antibodies
Quantify protein level changes relative to stress intensity and duration
Stress-dependent localization:
Perform immunofluorescence using YPR059C antibodies before and after oxidative stress
Co-stain with organelle markers (mitochondria, nucleus, ER)
Quantify potential translocation events using image analysis software
Compare wild-type localization with mutants defective in stress response pathways
Protein interaction dynamics:
Perform co-immunoprecipitation with YPR059C antibodies under normal and stress conditions
Identify stress-specific interaction partners using mass spectrometry
Validate key interactions using reciprocal co-IP or proximity ligation assays
Map interaction changes to specific stress response phases
Chromatin association patterns:
Conduct ChIP-seq with YPR059C antibodies under varying stress conditions
Identify condition-specific genomic binding sites
Correlate with transcriptional changes of associated genes
Integrate with binding data for known stress-response transcription factors
What methodologies can resolve contradictions between YPR059C antibody studies and uORF functional analysis?
Research has shown that YPR059C contains a uORF (upstream Open Reading Frame) that acts as a weak repressor . When antibody studies produce results contradicting uORF functional data:
Integration of protein and transcript analysis:
Perform parallel quantification of:
YPR059C protein using validated antibodies (Western blot)
YPR059C mRNA using RT-qPCR
uORF translation using ribosome profiling
Calculate protein-to-mRNA ratios to identify translational regulation
Correlate uORF usage with main ORF translation efficiency
Mutational analysis approach:
Generate constructs with modified uORF sequences:
uORF-eliminated variants
uORF start codon mutants
uORF-main ORF distance variants
Compare expression levels using YPR059C antibodies
Perform polysome profiling to assess translational efficiency
Correlate with reporter assays measuring functional output
Spatial organization analysis:
Use antibodies recognizing different YPR059C epitopes to determine:
Full-length protein localization
Potential truncated protein products
Alternative translation start site usage
Compare with fluorescent reporter constructs containing uORF modifications
Assess co-localization patterns with translation machinery components
Temporal dynamics investigation:
Study the kinetics of YPR059C expression after transcriptional activation
Compare timing of mRNA production, uORF translation, and main ORF translation
Correlate with changes in cellular physiology using functional assays
How can advanced ChIP-seq analysis with YPR059C antibodies inform gene regulatory network modeling?
Using YPR059C antibodies for ChIP-seq enables sophisticated regulatory network analysis:
Integrative genomics workflow:
Perform high-resolution ChIP-seq with optimized antibody conditions
Use spike-in normalization for quantitative comparisons
Generate biological triplicates for statistical robustness
Include input controls and YPR059C deletion controls
Execute multi-modal data integration
Correlate binding sites with RNA-seq expression data
Overlay with chromatin accessibility data (ATAC-seq)
Integrate with histone modification patterns (H3K4me3, H3K27ac)
Apply network inference algorithms
Identify direct YPR059C regulatory targets
Distinguish activating vs. repressive interactions
Determine feedback and feed-forward loops
Validate key regulatory connections
Perform reporter assays with YPR059C binding site mutations
Use CRISPRi to target YPR059C binding regions
Measure expression changes in YPR059C mutants
Analysis of binding dynamics across conditions:
| Condition | Binding Site Distribution | Motif Enrichment | Co-factors | Biological Function |
|---|---|---|---|---|
| Normal growth | Baseline genome-wide mapping | Primary motif identification | Constitutive partners | Homeostatic regulation |
| Oxidative stress | Stress-specific target acquisition | Secondary motifs | Stress-induced partners | Adaptive response |
| Nutrient limitation | Metabolic gene targeting | Condition-specific motifs | Metabolic regulators | Resource allocation |
| Cell cycle phases | Phase-specific binding patterns | Cell cycle motifs | Cyclins, CDKs | Cell division control |
This comprehensive approach enables construction of predictive models for YPR059C function within the broader gene regulatory network, particularly in the context of stress response mechanisms.